Related Experiment Video
Updated: Feb 28, 2026
09:43
Epithelial Cell Repopulation and Preparation of Rodent Extracellular Matrix Scaffolds for Renal Tissue Development
Published on: August 10, 2015
16.6K
Amniotic fluid cells: current progress and emerging challenges in renal regeneration.
Stefano Da Sacco1, Laura Perin1, Sargis Sedrakyan2
1GOFARR Laboratory for Organ Regenerative Research and Cell Therapeutics, Children's Hospital Los Angeles, Division of Urology, Saban Research Institute, University of Southern California, 4650 Sunset Boulevard, Mailstop #35, Los Angeles, CA, 90027, USA.
Pediatric Nephrology (Berlin, Germany)
|June 17, 2017
Summary
Amniotic fluid stem cells show promise for kidney repair. This review explores their derivation, regenerative potential, and therapeutic applications for kidney diseases.
Area of Science:
- Regenerative Medicine
- Stem Cell Biology
- Nephrology
Background:
- Amniotic fluid contains stem cells with pluripotent and progenitor characteristics.
- These cells are explored for regenerative medicine across various organs, including the kidneys.
- Amniotic fluid stem cells offer potential for tissue engineering and cellular therapies.
Purpose of the Study:
- To review methods for deriving amniotic fluid stem cells and renal progenitors.
- To examine the application of these cells in renal repair and regeneration.
- To discuss current understanding, challenges, and therapeutic potential for kidney diseases.
Main Methods:
- Literature review of amniotic fluid stem cell derivation.
- Analysis of studies on renal progenitor cell applications.
- Discussion of immunoregulatory and paracrine mechanisms.
Main Results:
- Amniotic fluid stem cells can be derived using various methodologies.
- These cells demonstrate potential in preclinical models of kidney repair.
- Immunomodulatory and paracrine effects are key to their therapeutic action.
Conclusions:
- Amniotic fluid stem cells are a viable source for renal regenerative medicine.
- Further research is needed to overcome challenges in their clinical application.
- Paracrine signaling offers a promising therapeutic avenue for kidney diseases.
